Literature DB >> 6888373

Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.

K D Tew, L C Erickson, G White, A L Wang, P S Schein, B Hartley-Asp.   

Abstract

Estramustine is cytotoxic in HeLa and Walker 256 carcinoma cells (with or without acquired resistance to nitrogen mustards) at concentrations equivalent to other alkylating agents. Even at lethal estramustine levels, no damage to DNA occurs. Instead, a disproportionately high amount of intact estramustine binds hydrophobically to the structural proteins of the nucleus, the nuclear matrix. In HeLa cells, estradiol receptors are absent, and estradiol per se is not toxic. Thus, estramustine has a mechanism of action distinct from that of steroids and alkylating agents and may induce cytotoxicity through interactions with the proteins of the nuclear matrix.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6888373

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.

Authors:  K D Tew; M E Stearns
Journal:  Urol Res       Date:  1987

2.  Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.

Authors:  P Behnam-Motlagh; O Jonsson; K G Engström; R Henriksson; K Grankvist
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Dansylated estramustine, a fluorescent probe for studies of estramustine uptake and identification of intracellular targets.

Authors:  M E Stearns; D P Jenkins; K D Tew
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 4.  Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.

Authors:  I Könyves
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

5.  Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.

Authors:  L A Speicher; V R Sheridan; A K Godwin; K D Tew
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

6.  Overcoming docetaxel resistance in prostate cancer: a perspective review.

Authors:  Clara Hwang
Journal:  Ther Adv Med Oncol       Date:  2012-11       Impact factor: 8.168

7.  DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.

Authors:  C Vallbo; T Bergenheim; A Bergh; K Grankvist; R Henriksson
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.